Drug Discovery News
-
Singapore's first flu vaccine clears phase I trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...Read more
-
Exjade gets FDA nod for iron overload treatment
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 24 Jan, 2013
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years...Read more
-
Customized treatments to dominate oncology therapy
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 11 Jul, 2012
Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering s...Read more
-
GSK, Theravance seek EU nod for COPD drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2013
Singapore: GlaxoSmithKline (GSK) and Theravance submitted a regulatory application in the European Union for the investi...Read more
-
Role of oxidative stress in autism disorder found
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: In an effort to explore biological influences on the varying appearance of autism spectrum disorder (ASD), Dr...Read more
-
CSL Behring progresses on novel drug for Hemophilia A
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...Read more
-
Sanofi begins biopharmaceutical plant construction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...Read more
-
Allied abdominal hernia study shows +ve results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...Read more
-
Biotron's HIV drug candidate reverses impaired immune system
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...Read more
-
GRPE elements to help cure HIV via gene therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2013
Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could...Read more
-
Charles River manages 2.9% growth in Q2, 2013
Drug Discovery | Company results | By BioSpectrum Bureau | 11 Comment | 01 Aug, 2013
Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...Read more
-
Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...Read more
-
Study: Novartis' Afinitor hinders kidney tumor
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2013
Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...Read more
-
Concert Pharma, Celgene enter in $300 mn merger
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...Read more
-
Mother's antibodies may cause autism
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibod...Read more
-
CellSeed withdraws stem cell drug application
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013
Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...Read more
-
Biodiem develops killer for drug-resistant microbes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...Read more
-
Afatinib proves efficacy in lung cancer treatment
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irre...Read more
